nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—CYP2D6—Lomustine—brain cancer	0.206	0.569	CbGbCtD
Mesoridazine—CYP2D6—Hydroxyurea—brain cancer	0.156	0.431	CbGbCtD
Mesoridazine—HTR2C—choroid plexus—brain cancer	0.0652	0.113	CbGeAlD
Mesoridazine—DRD3—telencephalic ventricle—brain cancer	0.0343	0.0597	CbGeAlD
Mesoridazine—HTR2A—choroid plexus—brain cancer	0.0327	0.0569	CbGeAlD
Mesoridazine—HRH1—nose—brain cancer	0.0252	0.0439	CbGeAlD
Mesoridazine—HTR6—ganglion—brain cancer	0.0206	0.0358	CbGeAlD
Mesoridazine—HTR2C—telencephalic ventricle—brain cancer	0.0191	0.0332	CbGeAlD
Mesoridazine—HTR2A—trigeminal nerve—brain cancer	0.0165	0.0288	CbGeAlD
Mesoridazine—HTR2A—cerebellar cortex—brain cancer	0.0165	0.0287	CbGeAlD
Mesoridazine—HTR1A—telencephalic ventricle—brain cancer	0.0161	0.028	CbGeAlD
Mesoridazine—HTR2A—vein—brain cancer	0.0149	0.026	CbGeAlD
Mesoridazine—DRD2—telencephalic ventricle—brain cancer	0.0145	0.0253	CbGeAlD
Mesoridazine—HTR2C—ganglion—brain cancer	0.0119	0.0207	CbGeAlD
Mesoridazine—HTR2A—cranial nerve—brain cancer	0.0118	0.0205	CbGeAlD
Mesoridazine—HTR2A—pons—brain cancer	0.0116	0.0203	CbGeAlD
Mesoridazine—Trifluoperazine—S100A4—brain cancer	0.0108	0.535	CrCbGaD
Mesoridazine—HTR1A—ganglion—brain cancer	0.01	0.0174	CbGeAlD
Mesoridazine—HTR2A—telencephalic ventricle—brain cancer	0.00958	0.0167	CbGeAlD
Mesoridazine—DRD2—ganglion—brain cancer	0.00904	0.0157	CbGeAlD
Mesoridazine—HTR2A—pineal body—brain cancer	0.00831	0.0145	CbGeAlD
Mesoridazine—HTR6—telencephalon—brain cancer	0.00794	0.0138	CbGeAlD
Mesoridazine—HTR1A—hindbrain—brain cancer	0.00759	0.0132	CbGeAlD
Mesoridazine—DRD2—hindbrain—brain cancer	0.00686	0.0119	CbGeAlD
Mesoridazine—HTR2A—ganglion—brain cancer	0.00596	0.0104	CbGeAlD
Mesoridazine—HTR2C—brainstem—brain cancer	0.00517	0.00899	CbGeAlD
Mesoridazine—HTR2A—endothelium—brain cancer	0.00514	0.00895	CbGeAlD
Mesoridazine—DRD3—head—brain cancer	0.00513	0.00893	CbGeAlD
Mesoridazine—HTR6—head—brain cancer	0.00494	0.0086	CbGeAlD
Mesoridazine—CHRM2—telencephalon—brain cancer	0.00476	0.00828	CbGeAlD
Mesoridazine—HTR2A—blood vessel—brain cancer	0.00474	0.00825	CbGeAlD
Mesoridazine—DRD3—central nervous system—brain cancer	0.00469	0.00815	CbGeAlD
Mesoridazine—HTR2C—telencephalon—brain cancer	0.00459	0.00798	CbGeAlD
Mesoridazine—HTR2A—hindbrain—brain cancer	0.00452	0.00787	CbGeAlD
Mesoridazine—HTR6—central nervous system—brain cancer	0.00451	0.00785	CbGeAlD
Mesoridazine—HTR1A—brainstem—brain cancer	0.00435	0.00757	CbGeAlD
Mesoridazine—CYP2D6—hindbrain—brain cancer	0.00412	0.00717	CbGeAlD
Mesoridazine—DRD2—brainstem—brain cancer	0.00393	0.00684	CbGeAlD
Mesoridazine—HTR1A—telencephalon—brain cancer	0.00386	0.00672	CbGeAlD
Mesoridazine—DRD3—brain—brain cancer	0.00372	0.00647	CbGeAlD
Mesoridazine—HTR2C—medulla oblongata—brain cancer	0.0036	0.00627	CbGeAlD
Mesoridazine—HTR6—brain—brain cancer	0.00358	0.00623	CbGeAlD
Mesoridazine—DRD2—telencephalon—brain cancer	0.00349	0.00607	CbGeAlD
Mesoridazine—KCNH2—telencephalon—brain cancer	0.00344	0.00598	CbGeAlD
Mesoridazine—Eletriptan—CYP2C9—brain cancer	0.00331	0.163	CrCbGaD
Mesoridazine—HTR2C—midbrain—brain cancer	0.00329	0.00573	CbGeAlD
Mesoridazine—HTR2C—spinal cord—brain cancer	0.00321	0.00559	CbGeAlD
Mesoridazine—CHRM2—endocrine gland—brain cancer	0.003	0.00522	CbGeAlD
Mesoridazine—CHRM2—head—brain cancer	0.00296	0.00515	CbGeAlD
Mesoridazine—HTR2C—head—brain cancer	0.00286	0.00497	CbGeAlD
Mesoridazine—DRD2—pituitary gland—brain cancer	0.00284	0.00494	CbGeAlD
Mesoridazine—KCNH2—pituitary gland—brain cancer	0.0028	0.00487	CbGeAlD
Mesoridazine—HTR1A—midbrain—brain cancer	0.00277	0.00482	CbGeAlD
Mesoridazine—HRH1—telencephalon—brain cancer	0.00275	0.00479	CbGeAlD
Mesoridazine—HTR1A—spinal cord—brain cancer	0.0027	0.00471	CbGeAlD
Mesoridazine—CHRM2—central nervous system—brain cancer	0.0027	0.00471	CbGeAlD
Mesoridazine—KCNH2—medulla oblongata—brain cancer	0.0027	0.0047	CbGeAlD
Mesoridazine—HTR2C—central nervous system—brain cancer	0.00261	0.00454	CbGeAlD
Mesoridazine—HTR2A—brainstem—brain cancer	0.00259	0.00451	CbGeAlD
Mesoridazine—DRD2—midbrain—brain cancer	0.0025	0.00436	CbGeAlD
Mesoridazine—KCNH2—midbrain—brain cancer	0.00247	0.00429	CbGeAlD
Mesoridazine—HTR1A—endocrine gland—brain cancer	0.00243	0.00424	CbGeAlD
Mesoridazine—KCNH2—spinal cord—brain cancer	0.00241	0.00419	CbGeAlD
Mesoridazine—HTR1A—head—brain cancer	0.0024	0.00418	CbGeAlD
Mesoridazine—CYP2D6—brainstem—brain cancer	0.00236	0.00411	CbGeAlD
Mesoridazine—HTR2A—telencephalon—brain cancer	0.0023	0.004	CbGeAlD
Mesoridazine—DRD2—endocrine gland—brain cancer	0.0022	0.00383	CbGeAlD
Mesoridazine—HTR1A—central nervous system—brain cancer	0.00219	0.00382	CbGeAlD
Mesoridazine—DRD2—head—brain cancer	0.00217	0.00378	CbGeAlD
Mesoridazine—KCNH2—endocrine gland—brain cancer	0.00217	0.00377	CbGeAlD
Mesoridazine—CHRM2—brain—brain cancer	0.00215	0.00374	CbGeAlD
Mesoridazine—HTR1A—cerebellum—brain cancer	0.00214	0.00373	CbGeAlD
Mesoridazine—KCNH2—head—brain cancer	0.00214	0.00372	CbGeAlD
Mesoridazine—CYP2D6—telencephalon—brain cancer	0.0021	0.00365	CbGeAlD
Mesoridazine—HTR2C—brain—brain cancer	0.00207	0.0036	CbGeAlD
Mesoridazine—DRD2—central nervous system—brain cancer	0.00198	0.00345	CbGeAlD
Mesoridazine—KCNH2—central nervous system—brain cancer	0.00195	0.0034	CbGeAlD
Mesoridazine—DRD2—cerebellum—brain cancer	0.00194	0.00337	CbGeAlD
Mesoridazine—HTR2A—gonad—brain cancer	0.00192	0.00334	CbGeAlD
Mesoridazine—KCNH2—cerebellum—brain cancer	0.00191	0.00332	CbGeAlD
Mesoridazine—HTR2A—pituitary gland—brain cancer	0.00187	0.00326	CbGeAlD
Mesoridazine—HTR2A—medulla oblongata—brain cancer	0.00181	0.00314	CbGeAlD
Mesoridazine—HTR1A—brain—brain cancer	0.00174	0.00303	CbGeAlD
Mesoridazine—HRH1—endocrine gland—brain cancer	0.00174	0.00302	CbGeAlD
Mesoridazine—HRH1—head—brain cancer	0.00172	0.00298	CbGeAlD
Mesoridazine—Thioridazine—CYP2C9—brain cancer	0.00166	0.082	CrCbGaD
Mesoridazine—HTR2A—midbrain—brain cancer	0.00165	0.00287	CbGeAlD
Mesoridazine—HTR2A—spinal cord—brain cancer	0.00161	0.0028	CbGeAlD
Mesoridazine—DRD2—brain—brain cancer	0.00157	0.00274	CbGeAlD
Mesoridazine—HRH1—central nervous system—brain cancer	0.00157	0.00272	CbGeAlD
Mesoridazine—Promethazine—CYP2C9—brain cancer	0.00156	0.0771	CrCbGaD
Mesoridazine—KCNH2—brain—brain cancer	0.00155	0.0027	CbGeAlD
Mesoridazine—Perphenazine—CYP2C9—brain cancer	0.00153	0.0752	CrCbGaD
Mesoridazine—HTR2A—endocrine gland—brain cancer	0.00145	0.00252	CbGeAlD
Mesoridazine—HTR2A—head—brain cancer	0.00143	0.00249	CbGeAlD
Mesoridazine—Promazine—CYP2C9—brain cancer	0.00138	0.0678	CrCbGaD
Mesoridazine—CYP2D6—endocrine gland—brain cancer	0.00132	0.0023	CbGeAlD
Mesoridazine—HTR2A—central nervous system—brain cancer	0.00131	0.00228	CbGeAlD
Mesoridazine—CYP2D6—head—brain cancer	0.00131	0.00227	CbGeAlD
Mesoridazine—HTR2A—cerebellum—brain cancer	0.00128	0.00222	CbGeAlD
Mesoridazine—HRH1—brain—brain cancer	0.00124	0.00216	CbGeAlD
Mesoridazine—CYP2D6—central nervous system—brain cancer	0.00119	0.00207	CbGeAlD
Mesoridazine—CYP2D6—cerebellum—brain cancer	0.00116	0.00203	CbGeAlD
Mesoridazine—HTR2A—brain—brain cancer	0.00104	0.00181	CbGeAlD
Mesoridazine—CYP2D6—brain—brain cancer	0.000946	0.00165	CbGeAlD
Mesoridazine—DRD2—Signaling Pathways—GLI1—brain cancer	3.74e-05	0.000875	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HEY1—brain cancer	3.69e-05	0.000864	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GLI1—brain cancer	3.68e-05	0.000861	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HEY1—brain cancer	3.67e-05	0.00086	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GLI1—brain cancer	3.67e-05	0.000859	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—VAV1—brain cancer	3.64e-05	0.000852	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—DLL1—brain cancer	3.62e-05	0.000848	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GLI1—brain cancer	3.61e-05	0.000846	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—DLL1—brain cancer	3.6e-05	0.000843	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—VAV1—brain cancer	3.58e-05	0.000839	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—VAV1—brain cancer	3.57e-05	0.000837	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—PIK3CG—brain cancer	3.56e-05	0.000833	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SUFU—brain cancer	3.54e-05	0.00083	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SHH—brain cancer	3.53e-05	0.000827	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	3.52e-05	0.000823	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SUFU—brain cancer	3.49e-05	0.000816	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SUFU—brain cancer	3.48e-05	0.000815	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—TP53—brain cancer	3.46e-05	0.00081	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SUFU—brain cancer	3.42e-05	0.000802	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—GFAP—brain cancer	3.42e-05	0.000801	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TRPC6—brain cancer	3.41e-05	0.000797	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—GFAP—brain cancer	3.36e-05	0.000788	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—GFAP—brain cancer	3.36e-05	0.000786	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PTCH1—brain cancer	3.35e-05	0.000784	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SMO—brain cancer	3.35e-05	0.000784	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—VAV1—brain cancer	3.31e-05	0.000774	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—GFAP—brain cancer	3.3e-05	0.000773	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CYP2C9—brain cancer	3.26e-05	0.000764	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—VAV1—brain cancer	3.25e-05	0.000762	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—VAV1—brain cancer	3.25e-05	0.00076	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HEY1—brain cancer	3.24e-05	0.000759	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—PIK3CG—brain cancer	3.23e-05	0.000756	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—VAV1—brain cancer	3.19e-05	0.000748	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HEY1—brain cancer	3.19e-05	0.000747	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HEY1—brain cancer	3.18e-05	0.000745	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—DLL1—brain cancer	3.18e-05	0.000744	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NOTCH2—brain cancer	3.15e-05	0.000738	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HEY1—brain cancer	3.13e-05	0.000733	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—DLL1—brain cancer	3.13e-05	0.000732	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—DLL1—brain cancer	3.12e-05	0.000731	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SHH—brain cancer	3.08e-05	0.000721	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—DLL1—brain cancer	3.07e-05	0.000719	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SHH—brain cancer	3.06e-05	0.000717	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—PIK3CG—brain cancer	3.02e-05	0.000707	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VAV1—brain cancer	3e-05	0.000703	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TRPC6—brain cancer	2.97e-05	0.000695	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TRPC6—brain cancer	2.95e-05	0.000691	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SMO—brain cancer	2.92e-05	0.000683	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PTCH1—brain cancer	2.92e-05	0.000683	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PTCH1—brain cancer	2.9e-05	0.00068	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SMO—brain cancer	2.9e-05	0.00068	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—BSG—brain cancer	2.77e-05	0.000649	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—PIK3CG—brain cancer	2.74e-05	0.000642	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SHH—brain cancer	2.7e-05	0.000633	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NOTCH2—brain cancer	2.68e-05	0.000627	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SHH—brain cancer	2.66e-05	0.000623	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SHH—brain cancer	2.65e-05	0.000621	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	2.63e-05	0.000616	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	2.62e-05	0.000613	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SHH—brain cancer	2.61e-05	0.000611	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TRPC6—brain cancer	2.61e-05	0.00061	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HES1—brain cancer	2.58e-05	0.000605	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TRPC6—brain cancer	2.56e-05	0.0006	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PTCH1—brain cancer	2.56e-05	0.0006	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SMO—brain cancer	2.56e-05	0.0006	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TRPC6—brain cancer	2.56e-05	0.000599	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VAV1—brain cancer	2.55e-05	0.000598	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SMO—brain cancer	2.52e-05	0.00059	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PTCH1—brain cancer	2.52e-05	0.00059	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TRPC6—brain cancer	2.52e-05	0.00059	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SMO—brain cancer	2.52e-05	0.000589	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PTCH1—brain cancer	2.52e-05	0.000589	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—IL2—brain cancer	2.5e-05	0.000586	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PTCH1—brain cancer	2.48e-05	0.00058	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SMO—brain cancer	2.48e-05	0.00058	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PDGFRA—brain cancer	2.46e-05	0.000576	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	2.39e-05	0.00056	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SPP1—brain cancer	2.39e-05	0.000559	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—IDH1—brain cancer	2.39e-05	0.000558	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	2.38e-05	0.000557	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NOTCH2—brain cancer	2.33e-05	0.000546	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NOTCH2—brain cancer	2.32e-05	0.000543	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	2.31e-05	0.000541	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	2.27e-05	0.000532	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—IL2—brain cancer	2.27e-05	0.000532	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	2.27e-05	0.000531	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	2.23e-05	0.000523	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VAV1—brain cancer	2.22e-05	0.000521	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VAV1—brain cancer	2.21e-05	0.000518	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HES1—brain cancer	2.2e-05	0.000514	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IRS2—brain cancer	2.16e-05	0.000506	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—IL2—brain cancer	2.13e-05	0.000498	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	2.1e-05	0.000491	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PDGFRA—brain cancer	2.09e-05	0.000489	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	2.07e-05	0.000484	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	2.06e-05	0.000483	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOTCH2—brain cancer	2.05e-05	0.00048	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SPP1—brain cancer	2.03e-05	0.000475	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	2.03e-05	0.000475	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	2.02e-05	0.000472	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOTCH2—brain cancer	2.01e-05	0.000471	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.98e-05	0.000463	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VAV1—brain cancer	1.95e-05	0.000457	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—IL2—brain cancer	1.93e-05	0.000452	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VAV1—brain cancer	1.92e-05	0.00045	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VAV1—brain cancer	1.92e-05	0.000449	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HES1—brain cancer	1.91e-05	0.000448	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—APC—brain cancer	1.91e-05	0.000447	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.91e-05	0.000447	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HES1—brain cancer	1.9e-05	0.000446	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VAV1—brain cancer	1.89e-05	0.000442	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—ENO2—brain cancer	1.89e-05	0.000441	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.85e-05	0.000434	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.84e-05	0.000432	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IRS2—brain cancer	1.83e-05	0.00043	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.82e-05	0.000426	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.81e-05	0.000424	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SPP1—brain cancer	1.77e-05	0.000414	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SPP1—brain cancer	1.76e-05	0.000412	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—EGFR—brain cancer	1.74e-05	0.000407	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—IL2—brain cancer	1.68e-05	0.000394	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HES1—brain cancer	1.68e-05	0.000393	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—IL2—brain cancer	1.67e-05	0.000392	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HES1—brain cancer	1.65e-05	0.000387	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HES1—brain cancer	1.65e-05	0.000386	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—IL2—brain cancer	1.63e-05	0.000381	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HES1—brain cancer	1.62e-05	0.00038	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.62e-05	0.000379	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—APC—brain cancer	1.62e-05	0.000379	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.6e-05	0.000375	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.6e-05	0.000374	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IRS2—brain cancer	1.6e-05	0.000374	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—IL2—brain cancer	1.6e-05	0.000374	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IRS2—brain cancer	1.59e-05	0.000372	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.000368	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.57e-05	0.000368	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.000368	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SPP1—brain cancer	1.55e-05	0.000363	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.55e-05	0.000362	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SPP1—brain cancer	1.53e-05	0.000358	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SPP1—brain cancer	1.52e-05	0.000357	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SPP1—brain cancer	1.5e-05	0.000351	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—RELA—brain cancer	1.49e-05	0.000349	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—ERBB2—brain cancer	1.48e-05	0.000347	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—IL2—brain cancer	1.48e-05	0.000346	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—EGFR—brain cancer	1.48e-05	0.000346	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.00034	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.00034	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—IL2—brain cancer	1.43e-05	0.000334	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.41e-05	0.000331	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—APC—brain cancer	1.41e-05	0.000331	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.41e-05	0.000329	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—APC—brain cancer	1.41e-05	0.000329	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IRS2—brain cancer	1.4e-05	0.000329	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000323	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000323	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IRS2—brain cancer	1.36e-05	0.000318	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—IL2—brain cancer	1.34e-05	0.000314	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCND1—brain cancer	1.31e-05	0.000306	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.3e-05	0.000303	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.29e-05	0.000301	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.28e-05	0.0003	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—RELA—brain cancer	1.27e-05	0.000296	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—ERBB2—brain cancer	1.26e-05	0.000295	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.24e-05	0.00029	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APC—brain cancer	1.24e-05	0.00029	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.000286	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APC—brain cancer	1.22e-05	0.000286	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.000285	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APC—brain cancer	1.22e-05	0.000285	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APC—brain cancer	1.2e-05	0.00028	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.2e-05	0.00028	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—brain cancer	1.14e-05	0.000267	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—IL2—brain cancer	1.14e-05	0.000267	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—STAT3—brain cancer	1.13e-05	0.000265	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.13e-05	0.000264	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCND1—brain cancer	1.11e-05	0.00026	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.00026	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.00026	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—RELA—brain cancer	1.1e-05	0.000258	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.1e-05	0.000258	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—RELA—brain cancer	1.1e-05	0.000257	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.1e-05	0.000257	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—brain cancer	1.09e-05	0.000256	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.09e-05	0.000255	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MYC—brain cancer	1.05e-05	0.000246	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—brain cancer	1.03e-05	0.00024	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—IL2—brain cancer	9.94e-06	0.000233	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—IL2—brain cancer	9.89e-06	0.000231	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—brain cancer	9.69e-06	0.000227	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—RELA—brain cancer	9.69e-06	0.000227	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCND1—brain cancer	9.69e-06	0.000227	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCND1—brain cancer	9.64e-06	0.000226	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—ERBB2—brain cancer	9.63e-06	0.000225	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—STAT3—brain cancer	9.6e-06	0.000225	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	9.59e-06	0.000225	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	9.55e-06	0.000223	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—RELA—brain cancer	9.53e-06	0.000223	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—RELA—brain cancer	9.51e-06	0.000223	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—ERBB2—brain cancer	9.47e-06	0.000222	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—ERBB2—brain cancer	9.45e-06	0.000221	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—RELA—brain cancer	9.36e-06	0.000219	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—ERBB2—brain cancer	9.3e-06	0.000218	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MYC—brain cancer	8.92e-06	0.000209	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—IL2—brain cancer	8.73e-06	0.000204	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—brain cancer	8.72e-06	0.000204	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CG—brain cancer	8.65e-06	0.000203	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TP53—brain cancer	8.62e-06	0.000202	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—IL2—brain cancer	8.59e-06	0.000201	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—IL2—brain cancer	8.57e-06	0.000201	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCND1—brain cancer	8.51e-06	0.000199	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—brain cancer	8.45e-06	0.000198	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—IL2—brain cancer	8.43e-06	0.000197	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CTNNB1—brain cancer	8.42e-06	0.000197	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—brain cancer	8.4e-06	0.000197	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCND1—brain cancer	8.37e-06	0.000196	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—STAT3—brain cancer	8.36e-06	0.000196	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCND1—brain cancer	8.35e-06	0.000196	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—STAT3—brain cancer	8.32e-06	0.000195	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	8.29e-06	0.000194	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CTNNB1—brain cancer	8.27e-06	0.000194	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCND1—brain cancer	8.22e-06	0.000192	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	8.14e-06	0.000191	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MYC—brain cancer	7.77e-06	0.000182	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MYC—brain cancer	7.73e-06	0.000181	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—brain cancer	7.6e-06	0.000178	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—brain cancer	7.56e-06	0.000177	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—brain cancer	7.42e-06	0.000174	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—STAT3—brain cancer	7.34e-06	0.000172	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TP53—brain cancer	7.32e-06	0.000171	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—brain cancer	7.3e-06	0.000171	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—brain cancer	7.28e-06	0.00017	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—STAT3—brain cancer	7.23e-06	0.000169	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—STAT3—brain cancer	7.21e-06	0.000169	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—brain cancer	7.16e-06	0.000168	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—STAT3—brain cancer	7.09e-06	0.000166	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MYC—brain cancer	6.82e-06	0.00016	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MYC—brain cancer	6.71e-06	0.000157	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MYC—brain cancer	6.7e-06	0.000157	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—brain cancer	6.67e-06	0.000156	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MYC—brain cancer	6.59e-06	0.000154	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—brain cancer	6.57e-06	0.000154	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—brain cancer	6.55e-06	0.000153	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—brain cancer	6.45e-06	0.000151	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TP53—brain cancer	6.38e-06	0.000149	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TP53—brain cancer	6.35e-06	0.000149	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TP53—brain cancer	5.6e-06	0.000131	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TP53—brain cancer	5.51e-06	0.000129	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TP53—brain cancer	5.5e-06	0.000129	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TP53—brain cancer	5.41e-06	0.000127	CbGpPWpGaD
